273221-97-9

Basic information

• Product Name: BOC-L-TRANSPRO(4-CH2OH)
• Synonyms: 1,2-Pyrrolidinedicarboxylic acid, 4-(hydroxyMethyl)-, 1-(1,1-diMethylethyl) ester, (2S,4R)-;(2S,4R)-1-Boc-4-(hydroxymethyl)-pyrrolidine-2-carboxylic acid;BOC-L-TRANSPRO(4-CH2OH);(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(HYDROXYMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID
• CAS NO: 273221-97-9
• Molecular Formula: C11H19NO5
• Molecular Weight: 245.27
• Mol File: 273221-97-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 401°C at 760 mmHg
• Flash Point: 196.3°C
• Appearance: /
• Density: 1.240±0.06 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 4.24E-08mmHg at 25°C
• Refractive Index: 1.51
• CAS DataBase Reference: BOC-L-TRANSPRO(4-CH2OH)(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-L-TRANSPRO(4-CH2OH)(273221-97-9)
• EPA Substance Registry System: BOC-L-TRANSPRO(4-CH2OH)(273221-97-9)

Safety Data

• Hazardous Substances Data: 273221-97-9(Hazardous Substances Data)

Usage

General Description

BOC-L-TRANSPRO(4-CH2OH) is a chemical compound with the following properties: molecular formula C11H21NO6, molecular weight 263.29 g/mol, and exact mass 263.141144. It is also known by the synonyms N-BOC-L-TRANSPRO and N-BOC-L-THIOPRO. BOC-L-TRANSPRO(4-CH2OH) is a derivative of L-threonine, and its structure contains a BOC (tert-butyloxycarbonyl) protective group and an ethyl ester group. BOC-L-TRANSPRO(4-CH2OH) is commonly used in organic synthesis as a building block for peptides and other complex molecules. It is important to handle this compound with care as it may pose risks to health and safety if not used properly.

InChI:InChI=1/C11H19NO5/c1-11(2,3)17-10(16)12-5-7(6-13)4-8(12)9(14)15/h7-8,13H,4-6H2,1-3H3,(H,14,15)/t7-,8+/m1/s1

Upstream product

• 630424-90-7 1,4-p-tolylsulfanylcarbonyl-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester 
• 220047-92-7 1-tert-butyl 2-methyl (2S,4R)-4-hydroxymethylpyrrolidine-1,2-dicarboxylate 

Relevant articles and documents

Inhibitors of Hepatitis C Virus

Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Inhibitors of Hepatitis C Virus

Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

HEPATITIS C VIRUS INHIBITORS

Hepatitis C virus inhibitors are disclosed having the general formula:(I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds toinhibit HCV are also disclosed.